Bioequivalence Study of Empagliflozin Tablet in Healthy Participants.

Clinical trial NCT03771781 · COMPLETED

Trial details

NCT number: NCT03771781
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2018-04-16
Primary completion: 2018-05-25
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.